Applied DNA Sciences, Inc. Overview
Pro stress-test →Applied DNA Sciences is a biotechnology company commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets, now executing a yield-focused BNB digital asset treasury strategy. The company underwent a radical strategic pivot in October 2025, shifting from its traditional biotech operations to focus on cryptocurrency-based treasury management.
Strategic Profile
Pro stress-test →The new ticker BNBX reflects the company's stated shift to a BNB-based digital asset treasury strategy focused on yield generation and token accumulation within the Binance ecosystem, pursuing an actively managed approach that integrates decentralized finance protocols and Binance-specific strategies. The company authorized a comprehensive corporate restructuring that includes a 60% workforce reduction (16 employees) and is expected to yield substantial annualized cost savings of approximately $2.9 million.
Competitive Landscape
Pro stress-test →Applied DNA's traditional competitors in biotech DNA manufacturing (Zymergen, Ginkgo Bioworks) are now irrelevant following the company's strategic pivot. The company now competes in the crypto treasury management space against digital asset managers and DeFi protocols, an entirely different competitive landscape.
Industry Context
Applied DNA Sciences, Inc. operates in Digital Asset Treasury Management / Cryptocurrency (formerly Biotechnology).
Key facts
Founded: 1983 · Headquarters: Stony Brook, US · Employees: 27 · Revenue: $3.74M